These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 25171453

  • 1. Orbital rhabdomyosarcoma in children: a favorable primary suitable for a less-invasive treatment strategy.
    Boutroux H, Cellier C, Mosseri V, Helfre S, Levy C, Desjardins L, Plancher C, Freneaux P, Michon J, Orbach D.
    J Pediatr Hematol Oncol; 2014 Nov; 36(8):605-12. PubMed ID: 25171453
    [Abstract] [Full Text] [Related]

  • 2. Long-term evaluation of orbital rhabdomyosarcoma in children.
    Boutroux H, Levy C, Mosseri V, Desjardins L, Plancher C, Helfre S, Freneaux P, Cellier C, Orbach D.
    Clin Exp Ophthalmol; 2015 Nov; 43(1):12-9. PubMed ID: 24923774
    [Abstract] [Full Text] [Related]

  • 3. Second-line therapy in young patients with relapsed or refractory orbital rhabdomyosarcoma.
    Zloto O, Minard-Colin V, Boutroux H, Brisse HJ, Levy C, Kolb F, Bolle S, Carton M, Helfre S, Orbach D.
    Acta Ophthalmol; 2021 May; 99(3):334-341. PubMed ID: 32833335
    [Abstract] [Full Text] [Related]

  • 4. Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease.
    Crist WM, Anderson JR, Meza JL, Fryer C, Raney RB, Ruymann FB, Breneman J, Qualman SJ, Wiener E, Wharam M, Lobe T, Webber B, Maurer HM, Donaldson SS.
    J Clin Oncol; 2001 Jun 15; 19(12):3091-102. PubMed ID: 11408506
    [Abstract] [Full Text] [Related]

  • 5. Treatment of children with nonmetastatic paratesticular rhabdomyosarcoma: results of the Malignant Mesenchymal Tumors studies (MMT 84 and MMT 89) of the International Society of Pediatric Oncology.
    Stewart RJ, Martelli H, Oberlin O, Rey A, Bouvet N, Spicer RD, Godzinski J, Stevens MC, International Society of Pediatric Oncology.
    J Clin Oncol; 2003 Mar 01; 21(5):793-8. PubMed ID: 12610176
    [Abstract] [Full Text] [Related]

  • 6. Soft tissue sarcoma or malignant mesenchymal tumors in the first year of life: experience of the International Society of Pediatric Oncology (SIOP) Malignant Mesenchymal Tumor Committee.
    Orbach D, Rey A, Oberlin O, Sanchez de Toledo J, Terrier-Lacombe MJ, van Unnik A, Quintana E, Stevens MC.
    J Clin Oncol; 2005 Jul 01; 23(19):4363-71. PubMed ID: 15994146
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Primary chemotherapy in rhabdomyosarcomas and other malignant mesenchymal tumors of the orbit: results of the International Society of Pediatric Oncology MMT 84 Study.
    Rousseau P, Flamant F, Quintana E, Voute PA, Gentet JC.
    J Clin Oncol; 1994 Mar 01; 12(3):516-21. PubMed ID: 7509854
    [Abstract] [Full Text] [Related]

  • 9. Adherence to Treatment, Response and Patterns of Failure in Pediatric Parameningeal Rhabdomyosarcoma: Experience From a Tertiary Cancer Care Center From India.
    Roy S, Pathy S, Mohanti BK, Chander S, Biswas A.
    J Pediatr Hematol Oncol; 2017 Mar 01; 39(2):e62-e68. PubMed ID: 28060113
    [Abstract] [Full Text] [Related]

  • 10. Relapse after localized rhabdomyosarcoma: Evaluation of the efficacy of second-line chemotherapy.
    Winter S, Fasola S, Brisse H, Mosseri V, Orbach D.
    Pediatr Blood Cancer; 2015 Nov 01; 62(11):1935-41. PubMed ID: 26150380
    [Abstract] [Full Text] [Related]

  • 11. [Pediatric rhabdomyosarcoma of the infratemporal fossa].
    Rozan O, Janot F, Oberlin O, Schwaab G, Quintana E, Tran Ba Huy P, Georges B, Luboinski B.
    Ann Otolaryngol Chir Cervicofac; 2002 Sep 01; 119(4):195-201. PubMed ID: 12410115
    [Abstract] [Full Text] [Related]

  • 12. Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group.
    Meza JL, Anderson J, Pappo AS, Meyer WH, Children's Oncology Group.
    J Clin Oncol; 2006 Aug 20; 24(24):3844-51. PubMed ID: 16921036
    [Abstract] [Full Text] [Related]

  • 13. [Treatment of orbital rhabdomyosarcoma (author's transl)].
    Jürgensen OA, Reinartz G, Pichler E.
    Padiatr Padol; 1982 Aug 20; 17(2):329-39. PubMed ID: 7099686
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Does aggressive local treatment have an impact on survival in children with metastatic rhabdomyosarcoma?
    Ben Arush M, Minard-Colin V, Mosseri V, Defachelles AS, Bergeron C, Algret N, Fasola S, André N, Thebaud E, Corradini N, Bernier V, Martelli H, Ranchère D, Orbach D.
    Eur J Cancer; 2015 Jan 20; 51(2):193-201. PubMed ID: 25471261
    [Abstract] [Full Text] [Related]

  • 16. Outcome for children with group III rhabdomyosarcoma treated with or without radiotherapy.
    Viswanathan AN, Grier HE, Litman HJ, Perez-Atayde A, Tarbell NJ, Neuberg D, Shamberger RC, Marcus KJ.
    Int J Radiat Oncol Biol Phys; 2004 Mar 15; 58(4):1208-14. PubMed ID: 15001265
    [Abstract] [Full Text] [Related]

  • 17. [Update of orbital rhabdomyosarcoma therapy in children].
    Ducrey N, Nenadov-Beck M, Spahn B.
    J Fr Ophtalmol; 2002 Mar 15; 25(3):298-302. PubMed ID: 11941256
    [Abstract] [Full Text] [Related]

  • 18. Visual outcomes and late complications in paediatric orbital rhabdomyosarcoma.
    Eade E, Tumuluri K, Do H, Rowe N, Smith J.
    Clin Exp Ophthalmol; 2017 Mar 15; 45(2):168-173. PubMed ID: 27473389
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Long-term results in children with head and neck rhabdomyosarcoma: A report from the Italian Soft Tissue Sarcoma Committee.
    Affinita MC, Ferrari A, Milano GM, Scarzello G, De Leonardis F, Coccoli L, Pericoli R, Basso E, Zanetti I, Scagnellato A, Bisogno G.
    Pediatr Blood Cancer; 2018 Mar 15; 65(3):. PubMed ID: 29115716
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.